AstraZeneca Looks To Lifecycle Management, Emerging Markets, For Sales

With the clock ticking on the patent life of several of AstraZeneca's top products, the firm is kicking up its lifecycle management activities. So far in 2008, the firm has made 12 lifecycle submissions; in contrast, it submitted two new chemical entities in that time period